Your funds, side by side
The lines these funds hold in common, and the companies you own through them. Weights are the ones each document states, with no currency conversion.
- Franklin Biotechnology Discovery Fund Franklin Strategic Series · 86 lines · as of Apr 30, 2026 · 100.0 %
Add a second fund to see what the two hold in common.
The companies you hold through them
A company's weight in the portfolio is its weight inside each fund, times that fund's share of the portfolio. With no amounts given, the funds weigh the same.
| Holding | Franklin Biotechnology Discovery Fund |
|---|---|
| Jazz Pharmaceuticals PLC | 5.55 % |
| Amgen Inc | 4.75 % |
| Gilead Sciences Inc | 4.66 % |
| Regeneron Pharmaceuticals, Inc. | 4.16 % |
| Vertex Pharmaceuticals Inc | 4.02 % |
| Argenx SE | 3.69 % |
| Ascendis Pharma A/S | 2.87 % |
| Insmed Inc | 2.82 % |
| Revolution Medicines Inc | 2.82 % |
| Praxis Precision Medicines Inc | 2.51 % |
| Spyre Therapeutics Inc | 2.33 % |
| Dianthus Therapeutics Inc | 2.30 % |
| Guardant Health Inc | 2.09 % |
| Oruka Therapeutics Inc | 2.09 % |
| Mirum Pharmaceuticals Inc | 2.02 % |
| PTC Therapeutics Inc | 2.01 % |
| AstraZeneca PLC | 1.85 % |
| Neurocrine Biosciences Inc | 1.72 % |
| Bridgebio Pharma Inc | 1.66 % |
| Alnylam Pharmaceuticals Inc | 1.62 % |
| Abivax SA | 1.60 % |
| Ionis Pharmaceuticals Inc | 1.48 % |
| Mineralys Therapeutics Inc | 1.46 % |
| EyePoint Inc | 1.43 % |
| Eli Lilly & Co | 1.27 % |
| CG oncology Inc | 1.21 % |
| Indivior Pharmaceuticals Inc | 1.18 % |
| Benitec Biopharma Inc | 1.16 % |
| Arcutis Biotherapeutics Inc | 1.13 % |
| Syndax Pharmaceuticals Inc | 1.02 % |
1 funds, 86 lines read.